logo
Book a meeting
ALSP

Alsp

Biotechnology, Rockaway BLVD, La Jolla, , 11420, California, 11000, United States, 1-10 Employees

alspinc.com

  • LinkedIn

phone no Phone Number: 85********

Who is ALSP

ALSP Inc. (American Life Science Pharmaceuticals, Inc.), is a privately held company based in San Diego, California, developing new small molecule drugs for treating neurodegenerative dis...

Read More

lock icon Get Full Access
map
  • 11000 Rockaway BLVD, La Jolla, California, 11420, United States Headquarters: 11000 Rockaway BLVD, La Jolla, California, 11420, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $25 Million to $50 Million
  • Gregory Hook CEO:   Gregory Hook

industries-icon Industry: Biotechnology

SIC SIC Code: 7993 | NAICS Code: 424210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ALSP

ALSP Org Chart and Mapping

Gregory Hook

Gregory Hook

Chief Executive Officer

Employees
Lemos Alkaleos

Lemos Alkaleos

Partner

See Full Org Chart arrow
email-formate-icon
View Email Formats for ALSP
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding ALSP

Answer: ALSP's headquarters are located at Rockaway BLVD, La Jolla, , 11420, California, 11000, United States

Answer: ALSP's phone number is 85********

Answer: ALSP's official website is https://alspinc.com

Answer: ALSP's revenue is $25 Million to $50 Million

Answer: ALSP's SIC: 7993

Answer: ALSP's NAICS: 424210

Answer: ALSP has 1-10 employees

Answer: ALSP is in Biotechnology

Answer: ALSP contact info: Phone number: 85******** Website: https://alspinc.com

Answer: ALSP Inc. (American Life Science Pharmaceuticals, Inc.), is a privately held company based in San Diego, California, developing new small molecule drugs for treating neurodegenerative disease initially focused on traumatic brain injury and Alzheimer's disease. Our approach is to identify key enzymes in the brain, called proteases, which produce biologically active peptides, proteins or processes that are thought to underlie the disease. We then use those enzymes as targets for screening compounds that inhibit these proteases and thereby prevent the harmful effect caused by these peptides, proteins and processes to treat the disease. By using this innovative process, our goal is to create and advance highly-effective drug development strategies and products for treating not only traumatic brain injury and Alzheimer's disease, but other Neurodegenerative Conditions such as Huntington's disease, Parkinson's disease and MS, and recover quality of life for those patients and their families.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access